A temporal thymic selection switch and ligand binding kinetics constrain neonatal Foxp3+ Treg cell development
Brian D Stadinski1, Sydney J Blevins1, Nicholas A Spidale1
1Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA.
Nature Immunology
|June 19, 2019
Summary
Neonatal thymus selection of regulatory T (tTreg) cells depends on antigen specificity and timing. Specific T cell receptor interactions with self-antigens determine whether thymocytes become tTreg cells, develop into other T cells, or are eliminated.
Area of Science:
- Immunology
- Developmental Biology
- T cell biology
Background:
- Neonatal thymus generates Foxp3+ regulatory T (tTreg) cells crucial for immune homeostasis and preventing autoimmunity.
- The precise role of antigen specificity in neonatal tTreg cell selection remains unclear.
Purpose of the Study:
- To identify self-peptides recognized by neonatal tTreg cells.
- To investigate how antigen recognition and T cell receptor (TCR) interactions influence tTreg cell development.
Main Methods:
- Identification of 17 self-peptides recognized by neonatal tTreg cells.
- Fate-mapping studies of neonatal thymocytes specific for peptidyl arginine deiminase type IV (Padi4).
- Analysis of TCR dwell times and binding kinetics in relation to thymocyte selection.
Main Results:
- Discovered ligand specificity patterns for self-antigens, including age- and inflammation-dependent presentation.
- Demonstrated that moderate TCR dwell times favor export as tTreg cells, while short dwell times lead to CD4+ T cell development.
- Observed that long TCR dwell times induce negative selection, and a temporal switch in negative selection impacts tTreg development.
Conclusions:
- Neonatal tTreg cell selection is constrained by a temporal switch in negative selection and specific ligand binding kinetics.
- Antigen specificity, TCR dwell time, and developmental stage collectively regulate the neonatal tTreg cell selection window.
More Related Videos
Related Concept Videos
Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Ligand Binding Sites
8.7K
8.7K
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Ligand Binding and Linkage
4.0K
4.0K
Protein-Drug Binding: Mechanism and Kinetics
1.7K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.7K
The Equilibrium Binding Constant and Binding Strength
14.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K


